ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Articles

Japan's Denka shifts profit focus to medical from plastics

TOKYO -- Denki Kagaku Kogyo plans to earn 50% of group operating profit from its division that includes medical products by the year ending March 2018, a 13-percentage-point jump linked to a new diagnostic reagent's global release.

     The Japanese company intends to increase profit from its life science and environment products division to 30 billion yen ($244 million) by fiscal 2017, 170% over forecasts for the period ending March 2016. Denka also aims to boost profit on sales from the division by 2 percentage points to 10%. Denka wants to cut its dependence on the plastics division, shielding the company from volatile raw materials costs.

     Much of the growth is expected to come from overseas sales of a profitable cholesterol reagent set for wide release as early as next year. Denka sees the drug bringing in 10 billion yen in sales annually and hopes to take half of that from overseas, the U.S. and China in particular.

     Denka's acquisition Thursday of a 51% share of German biomedical company Icon Genetics also should boost business in the division. Denka will use Icon's production technology to accelerate the development of vaccines, tests and other products and boost production efficiency across the board.

(Nikkei)

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more